![Frontiers | M1 Polarization Markers Are Upregulated in Basal-Like Breast Cancer Molecular Subtype and Associated With Favorable Patient Outcome | Immunology Frontiers | M1 Polarization Markers Are Upregulated in Basal-Like Breast Cancer Molecular Subtype and Associated With Favorable Patient Outcome | Immunology](https://www.frontiersin.org/files/Articles/560074/fimmu-11-560074-HTML/image_m/fimmu-11-560074-g001.jpg)
Frontiers | M1 Polarization Markers Are Upregulated in Basal-Like Breast Cancer Molecular Subtype and Associated With Favorable Patient Outcome | Immunology
![PDF] Minireview: Basal-like breast cancer: from molecular profiles to targeted therapies. | Semantic Scholar PDF] Minireview: Basal-like breast cancer: from molecular profiles to targeted therapies. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/033bbabb417eeef47ec5346cab08e8b3afa8c698/2-Table1-1.png)
PDF] Minireview: Basal-like breast cancer: from molecular profiles to targeted therapies. | Semantic Scholar
![JPM | Free Full-Text | Circulating MicroRNAs as Prognostic and Therapeutic Biomarkers in Breast Cancer Molecular Subtypes | HTML JPM | Free Full-Text | Circulating MicroRNAs as Prognostic and Therapeutic Biomarkers in Breast Cancer Molecular Subtypes | HTML](https://www.mdpi.com/jpm/jpm-10-00098/article_deploy/html/images/jpm-10-00098-g001-550.jpg)
JPM | Free Full-Text | Circulating MicroRNAs as Prognostic and Therapeutic Biomarkers in Breast Cancer Molecular Subtypes | HTML
![Feasibility of Classification of Triple Negative Breast Cancer by Immunohistochemical Surrogate Markers - Clinical Breast Cancer Feasibility of Classification of Triple Negative Breast Cancer by Immunohistochemical Surrogate Markers - Clinical Breast Cancer](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/8523ab01-bfd7-41c0-95a5-6c6797314133/gr1_lrg.jpg)
Feasibility of Classification of Triple Negative Breast Cancer by Immunohistochemical Surrogate Markers - Clinical Breast Cancer
![BRCA1 Basal-like Breast Cancers Originate from Luminal Epithelial Progenitors and Not from Basal Stem Cells - ScienceDirect BRCA1 Basal-like Breast Cancers Originate from Luminal Epithelial Progenitors and Not from Basal Stem Cells - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1934590910003462-fx1.jpg)
BRCA1 Basal-like Breast Cancers Originate from Luminal Epithelial Progenitors and Not from Basal Stem Cells - ScienceDirect
![Surrogate molecular classification of breast carcinoma: A classification in need or a dilemma indeed Dewan K, Mandal AK - Oncol J India Surrogate molecular classification of breast carcinoma: A classification in need or a dilemma indeed Dewan K, Mandal AK - Oncol J India](https://www.ojionline.org/articles/2020/4/3/images/OncolJIndia_2020_4_3_79_301588_f1.jpg)
Surrogate molecular classification of breast carcinoma: A classification in need or a dilemma indeed Dewan K, Mandal AK - Oncol J India
![_Schematic illustrating various breast cancer subtypes. The blue and... | Download Scientific Diagram _Schematic illustrating various breast cancer subtypes. The blue and... | Download Scientific Diagram](https://www.researchgate.net/profile/William-Coleman-5/publication/227347688/figure/fig1/AS:340774030987268@1458258268213/Schematic-illustrating-various-breast-cancer-subtypes-The-blue-and-pink-rectangles.png)
_Schematic illustrating various breast cancer subtypes. The blue and... | Download Scientific Diagram
![Heterocellular gene signatures reveal luminal-A breast cancer heterogeneity and differential therapeutic responses | npj Breast Cancer Heterocellular gene signatures reveal luminal-A breast cancer heterogeneity and differential therapeutic responses | npj Breast Cancer](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41523-019-0116-8/MediaObjects/41523_2019_116_Fig1_HTML.png)
Heterocellular gene signatures reveal luminal-A breast cancer heterogeneity and differential therapeutic responses | npj Breast Cancer
![Lehman's triple negative breast cancer classification, gene ontology... | Download Scientific Diagram Lehman's triple negative breast cancer classification, gene ontology... | Download Scientific Diagram](https://www.researchgate.net/profile/Sandra-Santuario-Facio/publication/305635731/figure/fig1/AS:583109172305920@1516035468048/Lehmans-triple-negative-breast-cancer-classification-gene-ontology-and-proportion.png)
Lehman's triple negative breast cancer classification, gene ontology... | Download Scientific Diagram
![association of molecular and pathological markers by basal-like breast... | Download Scientific Diagram association of molecular and pathological markers by basal-like breast... | Download Scientific Diagram](https://www.researchgate.net/profile/Michael-Lisanti/publication/43355276/figure/tbl4/AS:759592501932033@1558112373970/association-of-molecular-and-pathological-markers-by-basal-like-breast-cancer-BLBC.png)
association of molecular and pathological markers by basal-like breast... | Download Scientific Diagram
![IJMS | Free Full-Text | p63 at the Crossroads between Stemness and Metastasis in Breast Cancer | HTML IJMS | Free Full-Text | p63 at the Crossroads between Stemness and Metastasis in Breast Cancer | HTML](https://www.mdpi.com/ijms/ijms-20-02683/article_deploy/html/images/ijms-20-02683-g001.png)
IJMS | Free Full-Text | p63 at the Crossroads between Stemness and Metastasis in Breast Cancer | HTML
![Molecular alterations in triple-negative breast cancer—the road to new treatment strategies - The Lancet Molecular alterations in triple-negative breast cancer—the road to new treatment strategies - The Lancet](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/925810dd-1ee8-44ba-b83f-2446b96ac822/gr1_lrg.jpg)
Molecular alterations in triple-negative breast cancer—the road to new treatment strategies - The Lancet
![Molecular subtyping and genomic profiling expand precision medicine in refractory metastatic triple-negative breast cancer: the FUTURE trial | Cell Research Molecular subtyping and genomic profiling expand precision medicine in refractory metastatic triple-negative breast cancer: the FUTURE trial | Cell Research](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41422-020-0375-9/MediaObjects/41422_2020_375_Fig1_HTML.png)
Molecular subtyping and genomic profiling expand precision medicine in refractory metastatic triple-negative breast cancer: the FUTURE trial | Cell Research
![Androgen receptor in triple negative breast cancer: A potential target for the targetless subtype - Cancer Treatment Reviews Androgen receptor in triple negative breast cancer: A potential target for the targetless subtype - Cancer Treatment Reviews](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/8f9f496c-9c53-4adb-bf41-a56eff895513/gr3_lrg.jpg)